DK1560819T3 - Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning - Google Patents

Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning

Info

Publication number
DK1560819T3
DK1560819T3 DK03781830T DK03781830T DK1560819T3 DK 1560819 T3 DK1560819 T3 DK 1560819T3 DK 03781830 T DK03781830 T DK 03781830T DK 03781830 T DK03781830 T DK 03781830T DK 1560819 T3 DK1560819 T3 DK 1560819T3
Authority
DK
Denmark
Prior art keywords
thc
cannabinoid
purification
esters
crystalline
Prior art date
Application number
DK03781830T
Other languages
English (en)
Inventor
John R Duchek
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of DK1560819T3 publication Critical patent/DK1560819T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK03781830T 2002-11-12 2003-11-06 Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning DK1560819T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42554302P 2002-11-12 2002-11-12
US43502702P 2002-12-20 2002-12-20
PCT/US2003/035599 WO2004043946A1 (en) 2002-11-12 2003-11-06 Cannabinoid crystalline derivatives and process of cannabinoid purification

Publications (1)

Publication Number Publication Date
DK1560819T3 true DK1560819T3 (da) 2009-02-09

Family

ID=32314593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03781830T DK1560819T3 (da) 2002-11-12 2003-11-06 Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning

Country Status (13)

Country Link
US (1) US7402686B2 (da)
EP (1) EP1560819B1 (da)
JP (1) JP2006508132A (da)
AT (1) ATE410419T1 (da)
AU (1) AU2003287585B2 (da)
CA (1) CA2504743C (da)
DE (1) DE60324011D1 (da)
DK (1) DK1560819T3 (da)
ES (1) ES2315548T3 (da)
MX (1) MXPA05004966A (da)
PT (1) PT1560819E (da)
SI (1) SI1560819T1 (da)
WO (1) WO2004043946A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
EP1773801A1 (de) 2004-07-19 2007-04-18 Cilag Ltd. Verfahren zur gewinnung von reinem tetrahydrocannabinol
EP1827393A4 (en) * 2004-12-09 2012-04-18 Insys Therapeutics Inc DRONABINOL FORMULATIONS WITH LABORATORY TEMPERATURE
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
NZ567029A (en) * 2005-09-29 2011-09-30 Amr Technology Inc Process for production of delta-9- tetrahydrocannabinol
US20080112895A1 (en) * 2006-08-04 2008-05-15 Insys Therapeutics Inc. Aqueous dronabinol formulations
GB0702895D0 (en) * 2007-02-14 2007-03-28 Resolution Chemicals Ltd Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
US20090181080A1 (en) * 2007-08-06 2009-07-16 Insys Therapeutics Inc. Oral cannabinnoid liquid formulations and methods of treatment
WO2009099868A1 (en) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US9539295B2 (en) 2014-12-05 2017-01-10 Bradley Michael Bohus Cannabidiol (CBD) enriched alcohol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
GB201910389D0 (en) * 2019-07-19 2019-09-04 Gw Pharma Ltd Novel compounds, methods for their manufacture, and uses thereof
WO2021012044A1 (en) 2019-07-22 2021-01-28 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
MX2022003189A (es) 2019-09-16 2022-06-08 Vapor Cartridge Tech Llc Sistema de administración de fármacos con sustratos apilables.
IL295338A (en) * 2020-02-06 2022-10-01 London Pharmaceuticals And Res Corporation Cannabinoid sulfate esters, their salts and those used in them

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507888A (en) 1966-08-30 1970-04-21 Searle & Co Process and intermediates for manufacture of 17-oxygenated estr-4-en-3-ones
US3728360A (en) 1971-08-31 1973-04-17 Little Inc A Ester derivatives of tetrahydrocannabinol
US4188495A (en) 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
US4206225A (en) 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4341906A (en) 1979-09-24 1982-07-27 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes
US4381399A (en) 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
GB9303911D0 (en) 1993-02-26 1993-04-14 Zeneca Ltd Chemical process
JP3384163B2 (ja) * 1994-11-09 2003-03-10 株式会社ニコン 顕微鏡対物レンズ
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
EP1771245A1 (en) 2004-06-23 2007-04-11 BP p.l.c. The synthesis of the micro-porous silica gel and its application to the preparation of catalysts for c2 oxygenates synthesis from syngas

Also Published As

Publication number Publication date
WO2004043946A1 (en) 2004-05-27
CA2504743A1 (en) 2004-05-27
AU2003287585B2 (en) 2009-05-07
EP1560819A1 (en) 2005-08-10
AU2003287585A1 (en) 2004-06-03
SI1560819T1 (sl) 2009-06-30
JP2006508132A (ja) 2006-03-09
US7402686B2 (en) 2008-07-22
CA2504743C (en) 2012-04-24
MXPA05004966A (es) 2005-08-02
DE60324011D1 (de) 2008-11-20
US20060094774A1 (en) 2006-05-04
PT1560819E (pt) 2008-11-03
ATE410419T1 (de) 2008-10-15
ES2315548T3 (es) 2009-04-01
EP1560819B1 (en) 2008-10-08

Similar Documents

Publication Publication Date Title
DK1560819T3 (da) Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning
CY1112347T1 (el) Διεργασια για την κρυσταλλωση της (r)- ή της (s)-λανσοπραζολης
DE60327545D1 (de) Prozess für das produktion von photochromen überlagerten produkte
DE60330732D1 (de) Wahrscheinlichkeitsschätzung zur klassifikation mittels des K nächsten Nachbarn
DE60322656D1 (de) Gerät zur Berechnung von Druck/Temperatur
DK1654438T3 (da) Fremgangsmåde til naturgasproduktion
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
IS2136B (is) Aðferð til nýmyndunar í iðnaði á metýldíester 5-amínó-3-karboxýmetýl-4-sýanó-2-þíófenkarboxýlsýru
NO20055257L (no) Ny fremgangsmate for syntesen av s-indolin-2-karboksylsyre og anvendelse derav i syntesen av perindopril
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
ATA7262002A (de) Fertigungssystem
MY143958A (en) Quinazolinone derivatives and their use as cb agonists
WO2003028665A3 (en) Methods for the purification of levofloxacin
NO20043472L (no) Fremgangsmate for fremstillingen av perindopril med hoy renhet og intermediater nyttige i syntesen
HUP0500285A2 (hu) Eljárások levofloxacin tisztítására
DE602004023786D1 (de) Herstellung von hochreinem Alkylgallium
ATE397620T1 (de) Aufreinigungsverfahren, das eine mikrofiltration bei erhöhten temperaturen beinhaltet
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DK1354876T3 (da) Fremgangsmåde til syntese af (2S,3aS,7aS)-perhydroindol-2-carboxylsyre og dennes estere og anvendelse heraf i syntesen af perindopril
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
ATE528278T1 (de) Herstellung von 2-(1,3-dimethylbutyl)anilin und anderen verzweigten, alkylsubstituierten anilinen
DK1420029T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1380591T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf
IS7477A (is) Aðferð við framleiðslu sýrusalts af gemifloxasíni